InfuSystem Holdings Capital Expenditures (CapEx) Growth & History (INFU)
InfuSystem Holdings's capital expenditures (capex) was $560,000 for fiscal 2025.
View full InfuSystem Holdings company overviewInfuSystem Holdings annual capital expenditures (capex) history
| Fiscal year | Period ended | Capital expenditures (CapEx) | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $560,000 | −$532,000 | −48.72% |
| 2024 | 2024-12-31 | $1.1M | $68,000 | +6.64% |
| 2023 | 2023-12-31 | $1.0M | $42,000 | +4.28% |
| 2022 | 2022-12-31 | $982,000 | $2,000 | +0.20% |
| 2021 | 2021-12-31 | $980,000 | −$114,000 | −10.42% |
| 2020 | 2020-12-31 | $1.1M | −$1.8M | −62.61% |
| 2019 | 2019-12-31 | $2.9M | $2.6M | +941.28% |
| 2018 | 2018-12-31 | $281,000 | $177,000 | +170.19% |
| 2017 | 2017-12-31 | $104,000 | −$64,000 | −38.10% |
| 2016 | 2016-12-31 | $168,000 | −$146,000 | −46.50% |
| 2015 | 2015-12-31 | $314,000 | −$1.7M | −84.26% |
| 2014 | 2014-12-31 | $2.0M | −$2.7M | −57.76% |
| 2013 | 2013-12-31 | $4.7M | −$1.8M | −27.80% |
| 2012 | 2012-12-31 | $6.5M | −$1.7M | −20.33% |
| 2011 | 2011-12-31 | $8.2M | $5.8M | +235.97% |
| 2010 | 2010-12-31 | $2.4M | −$2.2M | −47.01% |
| 2009 | 2009-12-31 | $4.6M | — | — |
InfuSystem Holdings quarterly capital expenditures (capex)
| Fiscal quarter | Period ended | Capital expenditures (CapEx) | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $91,000 | −$126,000 | −58.06% |
| Q1 2026 | 2026-03-31 | $157,000 | $26,000 | +19.85% |
| Q4 2025 | 2025-12-31 | $133,000 | −$397,000 | −74.91% |
| Q3 2025 | 2025-09-30 | $79,000 | $36,000 | +83.72% |
| Q2 2025 | 2025-06-30 | $217,000 | −$120,000 | −35.61% |
| Q1 2025 | 2025-03-31 | $131,000 | −$51,000 | −28.02% |
| Q4 2024 | 2024-12-31 | $530,000 | $122,000 | +29.90% |
| Q3 2024 | 2024-09-30 | $43,000 | −$79,000 | −64.75% |
| Q2 2024 | 2024-06-30 | $337,000 | $160,000 | +90.40% |
| Q1 2024 | 2024-03-31 | $182,000 | −$135,000 | −42.59% |
| Q4 2023 | 2023-12-31 | $408,000 | −$3,000 | −0.73% |
| Q3 2023 | 2023-09-30 | $122,000 | −$113,000 | −48.09% |
| Q2 2023 | 2023-06-30 | $177,000 | $19,000 | +12.03% |
| Q1 2023 | 2023-03-31 | $317,000 | $139,000 | +78.09% |
| Q4 2022 | 2022-12-31 | $411,000 | $38,000 | +10.19% |
| Q3 2022 | 2022-09-30 | $235,000 | −$38,000 | −13.92% |
| Q2 2022 | 2022-06-30 | $158,000 | −$38,000 | −19.39% |
| Q1 2022 | 2022-03-31 | $178,000 | $40,000 | +28.99% |
| Q4 2021 | 2021-12-31 | $373,000 | $144,000 | +62.88% |
| Q3 2021 | 2021-09-30 | $273,000 | $88,000 | +47.57% |
| Q2 2021 | 2021-06-30 | $196,000 | $45,000 | +29.80% |
| Q1 2021 | 2021-03-31 | $138,000 | −$391,000 | −73.91% |
| Q4 2020 | 2020-12-31 | $229,000 | −$5.9M | −96.24% |
| Q3 2020 | 2020-09-30 | $185,000 | −$932,000 | −83.44% |
| Q2 2020 | 2020-06-30 | $151,000 | −$4.2M | −96.54% |
| Q1 2020 | 2020-03-31 | $529,000 | −$3.0M | −85.04% |
| Q4 2019 | 2019-12-31 | $6.1M | $1.8M | +43.49% |
| Q3 2019 | 2019-09-30 | $1.1M | −$661,000 | −37.18% |
| Q2 2019 | 2019-06-30 | $4.4M | $2.7M | +168.52% |
| Q1 2019 | 2019-03-31 | $3.5M | $2.4M | +215.63% |
| Q4 2018 | 2018-12-31 | $4.2M | $1.5M | +55.60% |
| Q3 2018 | 2018-09-30 | $1.8M | $842,000 | +89.96% |
| Q2 2018 | 2018-06-30 | $1.6M | $745,000 | +84.85% |
| Q1 2018 | 2018-03-31 | $1.1M | $105,000 | +10.34% |
| Q4 2017 | 2017-12-31 | $2.7M | −$4.1M | −60.10% |
| Q3 2017 | 2017-09-30 | $936,000 | $746,000 | +392.63% |
| Q2 2017 | 2017-06-30 | $878,000 | −$3.0M | −77.56% |
| Q1 2017 | 2017-03-31 | $1.0M | −$2.3M | −69.00% |
| Q4 2016 | 2016-12-31 | $6.8M | −$2.2M | −24.76% |
| Q3 2016 | 2016-09-30 | $190,000 | $106,000 | +126.19% |
| Q2 2016 | 2016-06-30 | $3.9M | −$1.9M | −32.58% |
| Q1 2016 | 2016-03-31 | $3.3M | −$396,000 | −10.79% |
| Q4 2015 | 2015-12-31 | $9.1M | $3.9M | +75.45% |
| Q3 2015 | 2015-09-30 | $84,000 | −$2.6M | −96.82% |
| Q2 2015 | 2015-06-30 | $5.8M | $2.4M | +70.86% |
| Q1 2015 | 2015-03-31 | $3.7M | $2.5M | +225.64% |
| Q4 2014 | 2014-12-31 | $5.2M | $3.8M | +289.83% |
| Q3 2014 | 2014-09-30 | $2.6M | $1.8M | +217.79% |
| Q2 2014 | 2014-06-30 | $3.4M | $2.6M | +331.64% |
| Q1 2014 | 2014-03-31 | $1.1M | −$650,000 | −36.58% |
| Q4 2013 | 2013-12-31 | $1.3M | −$903,000 | −40.49% |
| Q3 2013 | 2013-09-30 | $832,000 | −$516,000 | −38.28% |
| Q2 2013 | 2013-06-30 | $787,000 | −$81,000 | −9.33% |
| Q1 2013 | 2013-03-31 | $1.8M | −$319,000 | −15.22% |
| Q4 2012 | 2012-12-31 | $2.2M | −$2.7M | −54.64% |
| Q3 2012 | 2012-09-30 | $1.3M | $436,000 | +47.81% |
| Q2 2012 | 2012-06-30 | $868,000 | $813,000 | +1478.18% |
| Q1 2012 | 2012-03-31 | $2.1M | −$342,000 | −14.03% |
| Q4 2011 | 2011-12-31 | $4.9M | — | — |
| Q3 2011 | 2011-09-30 | $912,000 | −$137,000 | −13.06% |
| Q2 2011 | 2011-06-30 | $55,000 | — | — |
| Q1 2011 | 2011-03-31 | $2.4M | — | — |
| Q3 2010 | 2010-09-30 | $1.0M | — | — |
InfuSystem Holdings capital expenditures (capex) trends
Over the last five fiscal years, InfuSystem Holdings's capital expenditures (capex) decreased from $1.1M to $560,000, a change of −$534,000. The latest reported quarter, Q2 2026, shows $91,000.
What capital expenditures (CapEx) mean
Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.
SEC-reported capital expenditures
TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review InfuSystem Holdings source filings ↗